Delivery Order SPE2DB20D3101-SPE2DB24FRSH6

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,286.28 firm fixed-price contract is for the supply of Clobazam 2.5 mg/ml suspension in 120 ml bottles. The contract has a completion date of December 14, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,369.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,174,760 units of the medication Clobazam 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,711.98 firm fixed price delivery order is for the supply of 4,567,393,696 units of clobazam 10 mg tablets. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of clobazam 10 mg tablets. The $3,920.91 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency providing medical supplies and equipment to the U.S. military. The contract has an ultimate completion date of October 23, 2024 and was not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,882.91 fixed-price delivery order is for the supply of 4,566,910 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $3,693.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,135,426 units of the medication clobazam 10 mg tablets. The award has an ultimate completion date of October 18, 2024 and is structured as a firm-fixed-price delivery order. No set-aside designation was used for this contract. Amerisourcebergen holds a...
This federal contract award of $9,728.52 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,074,533 units of the drug Clobazam 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of January 29, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award detailed here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,325.36 fixed-price delivery order is for the supply of 4,567,445,189 units of the drug clobazam 10 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,296.60 firm fixed-price delivery order is for the supply of 4,566,848,140 units of the prescription drug clobazam 10 mg tablets. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.91 Firm Fixed Price Delivery Order covers the supply of 4,566,975,795 units of the prescription drug Clobazam 10 mg Tablet in lots of 100. The award has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRSH6
    Delivery Order

This federal contract award, valued at $1,128.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Clobazam 2.5 mg/mL suspension in 120 mL containers, with a completion date of August 15, 2024. This order is not associated with any set-aside requirements, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:22 PM